Baxter International Inc. · NYSE:BAX
Baxter International — Investor Day (May 2022)
14 slides from Baxter International's investor day presentation, May 25, 2022
Slide 1: Renal Care
RENAL CARE LEE ANN SCHUETTE President, Renal Care
Slide 2: Forward-Looking Statements
Forward-Looking Statements The presentations being made on May 25, 2022 include forward-looking statements concerning Baxter’s financial results, R&D pipeline, including planned product launches (many of which are subject to regulatory approval and may require additional investment) and results of c
Slide 3: Baxter Renal Care: Who We Are
Baxter Renal Care: Who We Are • 70+ year history as an innovator in Renal Care • A recognized global leader in Peritoneal Dialysis and Hemodialysis • Focus on innovation to broaden access to care in underserved and undiagnosed patients • Enhancing connected care and remote patient management to impr
Slide 4: Global Market Expected To Grow ~4% Through 2025
Global Market Expected To Grow ~4% Through 2025 CAGR ~$16B Market Dynamics ~4% ~$14B Opportunities Peritoneal ~$4.3B • Substantial shift globally to home dialysis ~$3.5B Dialysis (PD) driven by: ~6% o Accelerating patient preference to conduct therapy at home, rise in telemedicine & innovation of co
Slide 5: Market-Leading Portfolio
Market-Leading Portfolio Peritoneal Dialysis Hemodialysis Enhance PD therapy adoption and extend time on Increase Expanded Hemodialysis (HDx) therapy therapy through innovation and market adoption through market expansion and improve expansion to help improve patient outcomes profitability PD Cycler
Slide 6: Strategy To Drive Above-Market Growth Of 4% - 5% Through 2025
Strategy To Drive Above-Market Growth Of 4% - 5% Through 2025 Innovation Market Expansion Operational Efficiency Connected Care: Market Development: Drive Efficiencies: • Deliver robust cadence of • Increase PD and Expanded • Capacity investments to connected solutions to Hemodialysis (HDx) therapy
Slide 7: Building On Our Leadership In Connected Care
Building On Our Leadership In Connected Care Category Leader In Remote Advancing Clinical Outcomes Patient Management • Robust set of clinical publications with 30+ peer-reviewed publications2 • Using Sharesource prolongs time on therapy by 3.4 months ~32 Million • Associated with reduction of 39% C
Slide 8: Expanding Connected Care And Monitoring Ecosystem
Expanding Connected Care And Monitoring Ecosystem Shifting From Reactive to Personalized and Proactive Care: Analytics enabling proactive interventions to help address key 1 causes of PD therapy dropout Adequest enabling HCPs to personalize therapy regimen Making it Easier to Start and Stay on Thera
Slide 9: Advancing The Standard Of Care With New Technologies
Advancing The Standard Of Care With New Technologies Product design goals: • Novel design to transform patient and customer experience Developing Next Generation Global • Connected Care ecosystem expansion APD Cycler • Remote service & troubleshooting • Lower total cost of therapy to help expand acc
Slide 10: Robust Innovation Pipeline Strengthens Baxter's Leadership
Robust Innovation Pipeline Strengthens Baxter’s Leadership Recent Near Term Future Launches Launches Launches Sharesource Predictive Next Generation Analytics Global APD Cycler Sharesource Analytics 1.0 Sharesource Adequest Home PD Solution Geographic Expansion Generation Sharesource myPD Patient Ar
Slide 11: Investments In Market Expansion Expected To Accelerate PD Penetration Globally
Investments In Market Expansion Expected To Accelerate PD Penetration Globally Market development efforts to further fuel PD growth: Advocacy for favorable policy and economics • PD-favorable policies (AAKHI) U.S. Peritoneal Dialysis Penetration1,2 • “Safer-at-Home” initiative Professional education
Slide 12: We Are Driving Towards A Compelling Future State
We Are Driving Towards A Compelling Future State Patient care is proactive The patient and clinic PD therapy penetration and personalized experience is transformed and growth is through innovation in through new therapy catalyzed globally connected care technologies Baxter'sBaxter's RenalRenalCare C
Slide 13: References
References Slide 5 • Devoe, D et al. “Patient Education and Peritoneal Dialysis Modality Selection: A Systematic Review and Meta-analysis”; American Journal of Kidney Disease 2016; 68(3):422-433 Slide 6 • “The use of Baxter’s Sharesource remote patient management platform with an automated peritonea
Slide 14: Baxter 2022 Investor Conference
Baxter 2022 Investor Conference Wigs ee,